Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display

被引:117
作者
Nicklin, SA
White, SJ
Watkins, SJ
Hawkins, RE
Baker, AH [1 ]
机构
[1] Univ Glasgow, Western Infirm, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland
[2] Univ Manchester, Paterson Inst Canc Res, Manchester M13 9PL, Lancs, England
[3] Univ Bristol, Bristol Heart Inst, Bristol BS8 1TH, Avon, England
关键词
bacteriophages; peptides; gene therapy; viruses; cells;
D O I
10.1161/01.CIR.102.2.231
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Gene transfer to vascular cells is a highly inefficient and nonselective process, defined by the lack of specific cell-surface receptors for both nonviral and viral gene delivery vectors. Methods and Results-We used filamentous phage display to isolate a panel of peptides that have the ability to bind selectively and efficiently to quiescent human umbilical vein endothelial cells (HUVECs) with reduced or negligible binding to nonendothelial cells, including vascular smooth muscle cells and hepatocytes. By direct biopanning on HUVECs and a second approach involving preclearing steps before panning on HUVECs, we isolated and sequenced 140 individual phages and identified 59 peptides, We selected 7 candidates for further investigation by secondary screening of homogeneous phages on a panel of cell types. Using adenovirus-mediated gene transfer as a model gene delivery system, we cloned the peptide SIGYPLP and the positive control peptide KKKKKKK upstream of the S11e single-chain Fv (" adenobody") directed against the knob domain of the adenovirus to create fusion proteins. Adenovirus-mediated gene transfer via fiber-dependent infection was blocked with S11e, whereas inclusion of the KKKKKKK peptide retargeted gene transfer. The peptide SIGYPLP, however, retargeted gene delivery specifically to endothelial cells with a significantly enhanced efficiency over nontargeted adenovirus and without transduction of nontarget cells. Conclusions-Our study demonstrates the feasibility of using small, novel peptides isolated via phage display to target gene delivery specifically and efficiently to HUVECs and highlights their use for retargeting both viral and nonviral gene transfer to vascular endothelial cells for future clinical applications.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 33 条
  • [1] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
    Arap, W
    Pasqualini, R
    Ruoslahti, E
    [J]. SCIENCE, 1998, 279 (5349) : 377 - 380
  • [2] Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries
    Barry, MA
    Dower, WJ
    Johnston, SA
    [J]. NATURE MEDICINE, 1996, 2 (03) : 299 - 305
  • [3] Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
    Bergelson, JM
    Cunningham, JA
    Droguett, G
    KurtJones, EA
    Krithivas, A
    Hong, JS
    Horwitz, MS
    Crowell, RL
    Finberg, RW
    [J]. SCIENCE, 1997, 275 (5304) : 1320 - 1323
  • [4] CHERESH DA, 1987, J BIOL CHEM, V262, P17703
  • [5] PEPTIDES ON PHAGE - A VAST LIBRARY OF PEPTIDES FOR IDENTIFYING LIGANDS
    CWIRLA, SE
    PETERS, EA
    BARRETT, RW
    DOWER, WJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) : 6378 - 6382
  • [6] Targeted gene delivery by tropism-modified adenoviral vectors
    Douglas, JT
    Rogers, BE
    Rosenfeld, ME
    Michael, SI
    Feng, MZ
    Curiel, DT
    [J]. NATURE BIOTECHNOLOGY, 1996, 14 (11) : 1574 - 1578
  • [7] Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
    Girod, A
    Ried, M
    Wobus, C
    Lahm, H
    Leike, K
    Kleinschmidt, J
    Deléage, G
    Hallek, M
    [J]. NATURE MEDICINE, 1999, 5 (09) : 1052 - 1056
  • [8] GLADSON CL, 1994, INTEGRINS BIOL PROBL, P83
  • [9] Goldman CK, 1997, CANCER RES, V57, P1447
  • [10] Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin
    Harari, OA
    Wickham, TJ
    Stocker, CJ
    Kovesdi, I
    Segal, DM
    Huehns, TY
    Sarraf, C
    Haskard, DO
    [J]. GENE THERAPY, 1999, 6 (05) : 801 - 807